Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast Cancer
Clinical trial NCT07410559 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07410559
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2029-04-01
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.